alzheimer's semaglutide Ozempic linked to lower risk in people with Type 2 diabetes Semaglutide might reduce the risk

Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management

Use additional protection when starting or increasing GLP-1 doses If you just started taking a GLP-1 and are on birth control pills, you may want to add a second type of contraceptive to prevent pregnancy

Gradual dosing, smaller meals, and hydration can reduce discomfort Stay under medical supervision

Its introduction is a testament to the collaborative efforts of Incepta Pharmaceuticals Ltd., Onco Solution, and the wider medical community to elevate the standard of diabetes treatment worldwide